There were 63 and 62 selling days for the three months ended December 31, 2025 and 2024, respectively. There were 254 selling ...
Now Hear This is a monthly A&R column that provides you with exciting new sounds we discovered through the innovative new ...
The ROC held that undertaking new activities without prior amendment of the Memorandum breaches Section 4(1)(c). Even ...
The dispute concerned whether interior wall panels were builders ware or plastic sheets. The authority ruled they remain ...
Accuray Incorporated today reported financial results for the second quarter ended December 31, 2025. Key Highlights On December ...
The company's 10-Ks for fiscal year 2025 identify certain factors that could cause the company's actual results to differ ...
QIAGEN N.V. today announced results for the fourth quarter and full-year 2025. Net sales for Q4 2025 rose 4% to $540 million, with sales at constant exchange rates (CER) up 1% and exceeding the ...
The oncolytic virus therapy landscape has expanded steadily over the past decade, with over 100 companies worldwide pursuing clinical or preclinical programs. A few leaders, such as Candel Therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results